Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex total assets
Total assets on the balance sheet at the end of each period.
Vaccinex's total assets was $2.60M at Dec 31, 2024. For fiscal 2024 it was $2.60M, down 28.5% from the year before. The highest annual figure on record is $22.03M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.60M | -28.5% |
| FY2023 | Dec 31, 2023 | $3.63M | -54.5% |
| FY2022 | Dec 31, 2022 | $7.98M | -19.0% |
| FY2021 | Dec 31, 2021 | $9.84M | -15.9% |
| FY2020 | Dec 31, 2020 | $11.70M | +154.2% |
| FY2019 | Dec 31, 2019 | $4.60M | -79.1% |
| FY2018 | Dec 31, 2018 | $22.03M | +295.1% |
| FY2017 | Dec 31, 2017 | $5.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $2.60M | -28.5% |
| Q3 FY2024 | Sep 30, 2024 | $4.85M | +89.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.37M | -23.3% |
| Q1 FY2024 | Mar 31, 2024 | $7.37M | +50.5% |
| Q4 FY2023 | Dec 31, 2023 | $3.63M | -54.5% |
| Q3 FY2023 | Sep 30, 2023 | $2.56M | -70.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.09M | -75.5% |
| Q1 FY2023 | Mar 31, 2023 | $4.90M | -73.0% |
| Q4 FY2022 | Dec 31, 2022 | $7.98M | -19.0% |
| Q3 FY2022 | Sep 30, 2022 | $8.61M | -43.3% |
| Q2 FY2022 | Jun 30, 2022 | $12.57M | -47.2% |
| Q1 FY2022 | Mar 31, 2022 | $18.12M | -40.9% |
| Q4 FY2021 | Dec 31, 2021 | $9.84M | -15.9% |
| Q3 FY2021 | Sep 30, 2021 | $15.19M | -18.9% |
| Q2 FY2021 | Jun 30, 2021 | $23.79M | +667.6% |
| Q1 FY2021 | Mar 31, 2021 | $30.68M | +528.6% |
| Q4 FY2020 | Dec 31, 2020 | $11.70M | +154.2% |
| Q3 FY2020 | Sep 30, 2020 | $18.73M | +73.2% |
| Q2 FY2020 | Jun 30, 2020 | $3.10M | -56.5% |
| Q1 FY2020 | Mar 31, 2020 | $4.88M | -63.3% |
| Q4 FY2019 | Dec 31, 2019 | $4.60M | -79.1% |
| Q3 FY2019 | Sep 30, 2019 | $10.81M | -63.8% |
| Q2 FY2019 | Jun 30, 2019 | $7.12M | +51.0% |
| Q1 FY2019 | Mar 31, 2019 | $13.29M | +138.5% |
| Q4 FY2018 | Dec 31, 2018 | $22.03M | – |
| Q3 FY2018 | Sep 30, 2018 | $29.88M | – |
| Q2 FY2018 | Jun 30, 2018 | $4.72M | – |
| Q4 FY2017 | Dec 31, 2017 | $5.58M | – |
See a number that looks wrong?